Literature DB >> 7642593

Fluorescent peptidyl substrates as an aid in studying the substrate specificity of human prohormone convertase PC1 and human furin and designing a potent irreversible inhibitor.

F Jean1, A Boudreault, A Basak, N G Seidah, C Lazure.   

Abstract

The substrate specificities of two human prohormone convertases, furin and PC1, were examined with a series of 7-amino-4-methylcoumarinamide (MCA) containing peptidyl substrates. Using acetyl-Arg-Ser-Lys-Arg-MCA as model, P4 Arg substitution by Lys or Orn resulted for furin in a 538- and a 280-fold lower kcat/Km value, but only in a 14- and 18-fold decrease for PC1. Substitution of P3 Ser by either Pro, Glu, or Lys does not modify significantly the kcat/Km value for PC1, whereas furin activity is seriously impaired by the Glu substitution. Elongating the peptidyl sequence up to the P8 position decreases the kcat/Km value for furin but not for PC1. In both the P3 or P5 Glu substitution, the decrease of kcat/Km was due primarily to lower kcat rather than higher Km, possibly because of the presence of a negatively charged side chain. Finally, an octapeptidyl chloromethane derivative proved to be a potent irreversible inhibitor of either PC1 and ruin. The 811-fold difference in the apparent Kapp/[I] (1.63 x 10(6) s-1 m-1), and kcat/Km determined with the corresponding peptidyl MCA substrate (2.01 x 10(3) s-1 m-1), supports the proposal that cleavage of the acylenzyme represents the rate-limiting step for PC1 and furin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642593     DOI: 10.1074/jbc.270.33.19225

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Subtleties among subtilases. The structural biology of Kex2 and furin-related prohormone convertases.

Authors:  Charles Brenner
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

2.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Quantitative assessment of enzyme specificity in vivo: P2 recognition by Kex2 protease defined in a genetic system.

Authors:  A Bevan; C Brenner; R S Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 4.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.

Authors:  K Nakayama
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

5.  cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases.

Authors:  N G Seidah; J Hamelin; M Mamarbachi; W Dong; H Tardos; M Mbikay; M Chretien; R Day
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A.

Authors:  Xiaowei Sun; Rachid Essalmani; Delia Susan-Resiga; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

Review 7.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

8.  Enzymic characterization in vitro of recombinant proprotein convertase PC4.

Authors:  A Basak; B B Touré; C Lazure; M Mbikay; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

9.  Secreted antiviral entry inhibitory (SAVE) peptides for gene therapy of HIV infection.

Authors:  Lisa Egerer; Andreas Volk; Joerg Kahle; Janine Kimpel; Frances Brauer; Felix G Hermann; Dorothee von Laer
Journal:  Mol Ther       Date:  2011-03-01       Impact factor: 11.454

10.  BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development.

Authors:  Y Cui; F Jean; G Thomas; J L Christian
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.